A Double-Blind, Randomised, Parallel-Group Study of Pitavastatin in Familial Hypercholesterolemia in Childhood
Phase 3
- Conditions
- Familial hypercholesterolemia
- Registration Number
- JPRN-jRCT2080221734
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 14
Inclusion Criteria
Patients diagnosed with familial hypercholesterolemia
Exclusion Criteria
1. Previously taken pitavastatin
2. Need for other lipid lowering drugs
3. Diagnosed as homozygous familial hypercholesterolaemia
4. Requiring apheresis therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DL-C<br>Percent change from baseline LDL-C at Week 8 and Week 12
- Secondary Outcome Measures
Name Time Method DL-C,TC,TG,HDL-C,Apo-A1,Apo-B<br>Percent change from baseline at each visit